Sun.Mar 10, 2024

article thumbnail

HP&M’s Larry Houck A Panelist at FDLI’s Cannabis Regulation Conference

FDA Law Blog: Biosimilars

Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By doing so, FDA/HHS believe that cannabis no longer meets schedule I criteria but does not meet schedule II criteria either.

article thumbnail

How to Assign Records to Salesforce Queue: A Complete Guide

Perficient: Drug Development

Hello Trailblazers! With the need for effective customer data and records management increasing, Salesforce developed a solution called Salesforce Queue. Queues offer a dynamic solution, allowing users to efficiently organize, assign, and prioritize tasks and records. If you are not aware of what a Salesforce Queue is, how to create one, and its advantages, check out this previous blog.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Patent Expirations for the Week of March 10, 2024

Drug Patent Watch

SINUVA (mometasone furoate) Intersect ent inc Patent: 7,951,131 Expiration: Mar 12, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact… The post Drug Patent Expirations for the Week of March 10, 2024 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

How Important is Biostatistics?

thought leadership

The link between statistical methods and healthcare is not a new one, but the volume of available data to inform healthcare decisions and the use of data science in the medical industry has exploded in recent years.

Science 52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Understanding the role of Py4J in Databricks

Perficient: Drug Development

I mentioned that my attempt to implement TDD with Databricks was not totally successful. Setting up the local environment was not a problem and getting a service id for CI/CD component was more of an administrative than a technical problem. Using mocks to test python objects that are serialized to Spark is actually the issue. This is a feature, not a bug.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Netherlands?

Drug Patent Watch

This chart shows the drugs with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Netherlands? appeared first on DrugPatentWatch - Make Better Decisions.